Petreatment with interleukin-2 (IL-2) attenuates perioperative immunodysfunction in patients with renal cell carcinoma. - Böhm,M.; Ittenson,A.; Schierbaum,K.F.; Röhl,F-W.; Ansorge,S.; Allhoff,E.P. (Eur Urol, 2002)